» Articles » PMID: 22828580

Generalisability of The Health Improvement Network (THIN) Database: Demographics, Chronic Disease Prevalence and Mortality Rates

Overview
Date 2012 Jul 26
PMID 22828580
Citations 351
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: The degree of generalisability of patient databases to the general population is important for interpreting database research. This report describes the representativeness of The Health Improvement Network (THIN), a UK primary care database, of the UK population.

Methods: Demographics, deprivation (Townsend), Quality and Outcomes Framework (QOF) condition prevalence and deaths from THIN were compared with national statistical and QOF 2006/2007 data.

Results: Demographics were similar although THIN contained fewer people aged under 25 years. Condition prevalence was comparable, e.g. 3.5% diabetes prevalence in THIN, 3.7% nationally. More THIN patients lived in the most affluent areas (23.5% in THIN, 20% nationally). Between 1990 and 2009, standardised mortality ratio ranged from 0.81 (95% CI: 0.39-1.49; 1990) to 0.93 (95% CI: 0.48-1.64; 1995). Adjusting for demographics/deprivation, the 2006 THIN death rate was 9.08/1000 population close to the national death rate of 9.4/1000 population.

Conclusion: THIN is generalisable to the UK for demographics, major condition prevalence and death rates adjusted for demographics and deprivation.

Citing Articles

Ten years preceding a diagnosis of neurodegenerative disease in Europe and Australia: medication use, health conditions, and biomarkers associated with Alzheimer's disease, Parkinson's disease, and amyotrophic lateral sclerosis.

Wei D, Freydenzon A, Guinebretiere O, Zaidi K, Yang F, Ye W EBioMedicine. 2025; 113:105585.

PMID: 39914266 PMC: 11847299. DOI: 10.1016/j.ebiom.2025.105585.


Life expectancy and years of life lost for adults with diagnosed ADHD in the UK: matched cohort study.

ONions E, El Baou C, John A, Lewer D, Mandy W, McKechnie D Br J Psychiatry. 2025; :1-8.

PMID: 39844532 PMC: 7617439. DOI: 10.1192/bjp.2024.199.


Defining Mental Health Conditions Within Primary Care Data: A Validation Study With a Mixed Qualitative and Quantitative Approach.

Bazo-Alvarez J, Avgerinou C, Nimmons D, Hayes J, Osborn D, Cooper C J Eval Clin Pract. 2024; 31(1):e14256.

PMID: 39660636 PMC: 11632910. DOI: 10.1111/jep.14256.


The risk of immune-mediated inflammatory diseases following exposure to childhood maltreatment: A retrospective cohort study using UK primary care data.

Snook L, Minhas S, Nadda V, Hammond B, Gokhale K, Taylor J Heliyon. 2024; 10(22):e40493.

PMID: 39641040 PMC: 11617863. DOI: 10.1016/j.heliyon.2024.e40493.


Generalizability and treatment with sodium-glucose co-trasporter-2 inhibitors (SGLT2i) among patients with type 2 diabetes: an assessment using an Italian primary care database.

Antonazzo I, Rozza D, Cortesi P, Fornari C, Zanzottera Ferrari E, Paris C Acta Diabetol. 2024; 62(3):343-351.

PMID: 39207490 PMC: 11872765. DOI: 10.1007/s00592-024-02359-1.